Cell Source, Inc. (CLCS)

0.84 +0.02 (+2.74%) USD  |  OTCM  |  May 01, 16:00
More

Cell Source EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CLCS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Celldex Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Atossa Therapeutics, Inc. Upgrade
Abeona Therapeutics, Inc. Upgrade
Kiora Pharmaceuticals, Inc. Upgrade